Gianluca Pirozzi

Director/Board Member at TREX WIND-DOWN, INC.

Net worth: 1 $ as of 30/03/2024

47 year

Health Technology

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Ed Sitar	M	63	TREX WIND-DOWN, INC.	4 years
Sean Christie	M	-	ALEXION PHARMACEUTICALS, INC.	3 years
Lubor Gaal	M	56	TREX WIND-DOWN, INC.	4 years
Piyush Sharma	M	-	ALEXION PHARMACEUTICALS, INC.	7 years
David Cohen	M	59	TREX WIND-DOWN, INC.	4 years
Sarah Marshall	F	-	ALEXION PHARMACEUTICALS, INC.	10 years
Christophe Hotermans	M	-	ALEXION PHARMACEUTICALS, INC.	4 years
Ruth Diazaraque	M	-	ALEXION PHARMACEUTICALS, INC.	1 years
Seng Cheng	M	-	ALEXION PHARMACEUTICALS, INC.	1 years
Jessica Bruno-Raiz	F	-	TREX WIND-DOWN, INC.	5 years
Glen Frick	M	57	ALEXION PHARMACEUTICALS, INC.	-
Nicola Heffron	F	52	ALEXION PHARMACEUTICALS, INC.	1 years
Morgan Sanford	F	-	ALEXION PHARMACEUTICALS, INC.	-
Tamar Thompson	F	50	ALEXION PHARMACEUTICALS, INC.	5 years
Patryk Mikucki	M	49	ALEXION PHARMACEUTICALS, INC.	-
Frédéric Chéreau	M	57	ALEXION PHARMACEUTICALS, INC.	2 years
Marc Dunoyer	M	71	ALEXION PHARMACEUTICALS, INC.	-
Todd Spalding	M	-	ALEXION PHARMACEUTICALS, INC.	-

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
David Brennan	M	70	ALEXION PHARMACEUTICALS, INC.	7 years
Zachary Rome	M	40	TREX WIND-DOWN, INC.	2 years
John Koconis	M	54	TREX WIND-DOWN, INC.	4 years
Joe Lucchese	M	57	TREX WIND-DOWN, INC.	4 years
Felix Baker	M	55	ALEXION PHARMACEUTICALS, INC.	6 years
Rana Strellis	F	-	ALEXION PHARMACEUTICALS, INC.	4 years
Christopher Coughlin	M	71	ALEXION PHARMACEUTICALS, INC.	7 years
Susan Altschuller	M	42	ALEXION PHARMACEUTICALS, INC.	2 years
Michael T. Stocum	M	58	TREX WIND-DOWN, INC.	-
Scott Peters	M	-	ALEXION PHARMACEUTICALS, INC.	8 years
Michael Ira Kenneth Elloian	M	52	ALEXION PHARMACEUTICALS, INC.	-
Ludwig Hantson	M	61	ALEXION PHARMACEUTICALS, INC.	4 years
Ebun Garner	M	52	Imbria Pharmaceuticals, Inc. Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.	1 years
Jack Mollen	M	73	ALEXION PHARMACEUTICALS, INC.	7 years
Brian Goff	M	55	ALEXION PHARMACEUTICALS, INC.	4 years
Judith Reinsdorf	F	60	ALEXION PHARMACEUTICALS, INC.	3 years
Paul Friedman	M	81	ALEXION PHARMACEUTICALS, INC.	4 years
Anne-Marie Law	F	56	ALEXION PHARMACEUTICALS, INC.	3 years
Ellen Chiniara	F	65	ALEXION PHARMACEUTICALS, INC.	3 years
Francois Nader	M	67	ALEXION PHARMACEUTICALS, INC.	4 years
Deborah Dunsire	M	61	ALEXION PHARMACEUTICALS, INC.	3 years
Linda A. Broenniman	F	67	TREX WIND-DOWN, INC.	-
Andreas Rummelt	M	66	ALEXION PHARMACEUTICALS, INC.	11 years
Thierry Chauche	M	48	ALEXION PHARMACEUTICALS, INC.	1 years
Ai Min Hui	M	61	Sanofi SA	2 years
Angela Giannantonio	F	-	ALEXION PHARMACEUTICALS, INC.	-
Shane Doyle	M	-	ALEXION PHARMACEUTICALS, INC.	7 years
Megan Goulart	F	-	ALEXION PHARMACEUTICALS, INC.	-
Kristen Stants	F	51	ALEXION PHARMACEUTICALS, INC.	2 years
Adam Hansard	M	48	ALEXION PHARMACEUTICALS, INC.	1 years
Christopher Wick	M	-	ALEXION PHARMACEUTICALS, INC.	4 years
Alexandra Kropotova	M	51	Sanofi SA	9 years
Christopher Sorli	M	-	Sanofi SA	4 years
Uzair Qadeer	M	-	ALEXION PHARMACEUTICALS, INC.	2 years
Becky Lillie	F	-	ALEXION PHARMACEUTICALS, INC.	-
Rosemary Harrison	M	41	Imbria Pharmaceuticals, Inc. Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.	1 years
Alan Mendelsohn	M	62	TREX WIND-DOWN, INC.	3 years
Julia Wang	F	53	ALEXION PHARMACEUTICALS, INC.	2 years
Martine Zimmermann	M	55	ALEXION PHARMACEUTICALS, INC.	7 years
Holly Schachner	M	57	Sanofi SA	5 years
Sandra Jonsson	M	51	ALEXION PHARMACEUTICALS, INC.	-
Christopher Benecchi	M	-	ALEXION PHARMACEUTICALS, INC.	2 years
Michael Lisjak	M	50	Sanofi SA	1 years
Patrick Barry	M	-	Sanofi SA	24 years
Ann Miller	M	66	Sanofi SA	6 years
Amir Tavakkol	M	69	TREX WIND-DOWN, INC.	1 years
Paul Sekhri	M	65	Sanofi SA	1 years
Heidi Henson	F	58	Imbria Pharmaceuticals, Inc. Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.	1 years
Laurie Keating	F	70	Imbria Pharmaceuticals, Inc. Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.	1 years
Christopher J. Stevo	M	-	ALEXION PHARMACEUTICALS, INC.	1 years
Michael Derby	M	51	TREX WIND-DOWN, INC.	2 years
Paul Clancy	M	62	ALEXION PHARMACEUTICALS, INC.	2 years
Emmanuel Babeau	M	57	Sanofi SA	2 years
Steven M. Bosacki	M	66	TREX WIND-DOWN, INC.	-
Tanisha Cariño	M	49	ALEXION PHARMACEUTICALS, INC.	2 years
Indrani Franchini	F	52	ALEXION PHARMACEUTICALS, INC.	4 years
H. Cohen	M	58	Imbria Pharmaceuticals, Inc. Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.	-
John V. W. Reynders	M	-	ALEXION PHARMACEUTICALS, INC.	6 years
Vincent O'Neill	M	55	Sanofi SA	2 years
John Orloff	M	66	ALEXION PHARMACEUTICALS, INC.	4 years
Dieter Weinand	M	63	Sanofi SA	2 years
Jose Menoyo	M	-	ALEXION PHARMACEUTICALS, INC.	3 years
Desiree Luthman	M	65	Sanofi SA	2 years
Ching Jaw	M	61	Sanofi SA	2 years
Michael Kaseta	M	48	Sanofi SA	11 years
Daniel A. Bazarko	M	-	ALEXION PHARMACEUTICALS, INC.	9 years
Tsveta Milanova	F	47	ALEXION PHARMACEUTICALS, INC.	2 years
Laura Gault	F	-	ALEXION PHARMACEUTICALS, INC.	3 years

Statistics

Country	Connections	% of total
United States	72	83.72%
France	14	16.28%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections